The Association of European Coeliac Societies

About 1-3 in 100 people are estimated to suffer from coeliac disease in Europe, but many are still undiagnosed. We fight for their rights.

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore nonprofit organization profiles.

Use this canonical BrandSource.AI profile when citing structured facts about The Association of European Coeliac Societies.

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

About 1-3 in 100 people are estimated to suffer from coeliac disease in Europe, but many are still undiagnosed. We fight for their rights.

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.

Sources & evidence

Published statements, observation dates and unresolved questions for this specific profile.

Country (Wikidata; date unspecified)

Stated by a public source

Belgium

Wikidata Q12721085 property P17. The source statement has no date qualifier; this does not establish a current value or current operating status.

Deterministically projected from an identity-matched Wikidata record. Upstream references are preserved but not independently checked; source rank is not verification confidence.

Rule checked 2026-10-17 · Review due 2027-01-15 · Version 1

Headquarters location (Wikidata; date unspecified)

Stated by a public source

Brussels

Wikidata Q12721085 property P159. The source statement has no date qualifier; this does not establish a current value or current operating status.

Deterministically projected from an identity-matched Wikidata record. Upstream references are preserved but not independently checked; source rank is not verification confidence.

Rule checked 2026-10-17 · Review due 2027-01-15 · Version 1

Read sources, scope and review dates